Ipamorelin is a small peptide that tells the body to release its own growth hormone (a GH secretagogue). Compared with older peptides in its class, it’s marketed as “cleaner” — triggering less of the cortisol and prolactin release that made earlier compounds harder to use.
Human research on ipamorelin exists, but it’s about hormone pulses and safety at the endocrine level — not about healing an injury. No published human trial has tested ipamorelin for tendon repair, muscle recovery, or return-to-sport timelines.
Raising growth hormone is not the same claim as healing faster, and no study has connected the two for ipamorelin. A claim that jumps straight from “raises GH” to “heals an injury” is going further than the evidence supports.